218 related articles for article (PubMed ID: 33134711)
1. Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy.
Yousuf M; Khan P; Shamsi A; Shahbaaz M; Hasan GM; Haque QMR; Christoffels A; Islam A; Hassan MI
ACS Omega; 2020 Oct; 5(42):27480-27491. PubMed ID: 33134711
[TBL] [Abstract][Full Text] [Related]
2. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics.
Yousuf M; Shamsi A; Mohammad T; Azum N; Alfaifi SYM; Asiri AM; Mohamed Elasbali A; Islam A; Hassan MI; Haque QMR
ACS Omega; 2022 Jul; 7(29):25844-25852. PubMed ID: 35910117
[TBL] [Abstract][Full Text] [Related]
4. Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies.
Yousuf M; Shamsi A; Queen A; Shahbaaz M; Khan P; Hussain A; Alajmi MF; Rizwanul Haque QM; Imtaiyaz Hassan M
J Cell Biochem; 2021 Aug; 122(8):897-910. PubMed ID: 33829554
[TBL] [Abstract][Full Text] [Related]
5. Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics.
Yousuf M; Shamsi A; Khan S; Khan P; Shahwan M; Elasbali AM; Haque QMR; Hassan MI
Int J Biol Macromol; 2022 Jul; 213():944-954. PubMed ID: 35690164
[TBL] [Abstract][Full Text] [Related]
6. Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity.
Yousuf M; Khan S; Hussain A; Alajmi MF; Shamsi A; Haque QMR; Islam A; Hassan MI
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130624. PubMed ID: 38453105
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing.
Baig MH; Yousuf M; Khan MI; Khan I; Ahmad I; Alshahrani MY; Hassan MI; Dong JJ
Front Oncol; 2022; 12():865454. PubMed ID: 35720007
[TBL] [Abstract][Full Text] [Related]
8. Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy.
Dahiya R; Mohammad T; Roy S; Anwar S; Gupta P; Haque A; Khan P; Kazim SN; Islam A; Ahmad F; Hassan MI
Int J Biol Macromol; 2019 Sep; 136():1076-1085. PubMed ID: 31233792
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction of quercetin and its derivatives against nucleolin in breast cancer:
Shaw S; Chourasia M; Nayak R; Kumeria T; Ghosh MP; Santoshi S; Bose S
J Biomol Struct Dyn; 2024 Mar; ():1-12. PubMed ID: 38468538
[TBL] [Abstract][Full Text] [Related]
11. Controlling cell proliferation by targeting cyclin-dependent kinase 6 using drug repurposing approach.
Madhana Priya N; Balasundaram A; Sidharth Kumar N; Udhaya Kumar S; Thirumal Kumar D; Magesh R; Zayed H; George Priya Doss C
Adv Protein Chem Struct Biol; 2023; 135():97-124. PubMed ID: 37061342
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
Khuntawee W; Rungrotmongkol T; Hannongbua S
J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
[TBL] [Abstract][Full Text] [Related]
13. Targeting CDK6 in hormone receptor-positive breast cancer: inhibitor discovery for precision oncology through dynamics study.
Khatoon Z; Khalid M; Alqarni MH; Foudah AI; Annadurai S; Wahab S; Abdullah Almoyad MA
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38127416
[TBL] [Abstract][Full Text] [Related]
14. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy.
Gupta P; Mohammad T; Dahiya R; Roy S; Noman OMA; Alajmi MF; Hussain A; Hassan MI
Sci Rep; 2019 Dec; 9(1):18727. PubMed ID: 31822735
[TBL] [Abstract][Full Text] [Related]
16. In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.
Maruthanila VL; Elancheran R; Roy NK; Bhattacharya A; Kunnumakkara AB; Kabilan S; Kotoky J
Curr Comput Aided Drug Des; 2019; 15(1):89-96. PubMed ID: 30306879
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex.
Zhang J; Zhang L; Xu Y; Jiang S; Shao Y
PLoS One; 2018; 13(5):e0196651. PubMed ID: 29715320
[TBL] [Abstract][Full Text] [Related]
18. The anticancer potential of chemical constituents of Moringa oleifera targeting CDK-2 inhibition in estrogen receptor positive breast cancer using in-silico and in vitro approches.
Sultan R; Ahmed A; Wei L; Saeed H; Islam M; Ishaq M
BMC Complement Med Ther; 2023 Nov; 23(1):396. PubMed ID: 37925393
[TBL] [Abstract][Full Text] [Related]
19. Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics.
Chukwuemeka PO; Umar HI; Iwaloye O; Oretade OM; Olowosoke CB; Oretade OJ; Elabiyi MO
J Biomol Struct Dyn; 2022 Nov; 40(18):8518-8537. PubMed ID: 33890551
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
Yousif FA; Alzain AA; Alraih AM; Ibraheem W
PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
